Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COMy 2019 | CAR-T cells for myeloma: experience from China

CAR T-cell therapy stands as a topic of great interest and debate in multiple myeloma (MM), with many trials ongoing around the world. He Huang, MD, PhD, Zhejiang University School of Medicine, Zhejiang, China, presents an update on the CAR-T experience in China, discussing ongoing trials and developments in MM. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.